Metro Doctor's Medical License To Remain Suspended - News9.com - Oklahoma City, OK - News, Weather, Video and Sports |

Metro Doctor's Medical License To Remain Suspended

Posted: Updated:
A doctor accused of running a pill mill at Aria Orthopedics in Southwest OKC, fights to regain his ability to prescribe narcotics. A doctor accused of running a pill mill at Aria Orthopedics in Southwest OKC, fights to regain his ability to prescribe narcotics.
OKLAHOMA CITY -

A metro doctor's medical license will remain suspended after being accused of running a “pill mill”.

In February, Dr. Harvey Jenkins went before a judge to appeal the decision by Oklahoma Bureau of Narcotics to suspend his license to prescribe controlled substances.

2/18/15 Related Story: Metro Doctor Accused Of Running "Pill Mill" Fights Back

Jenkins had been under investigation for quite some time.

His offices at Aria Orthopedics, near SW 89th Street and Western Ave. were raided, after authorities suspected he was running a “pill mill”. In which, he was accused of Medicaid fraud, overprescribing, and writing scripts for patients he didn't treat.

Thursday, March 12, the medical board ruled that Jenkins'  medical license will continue to be suspended until his next review in September.

Special Features

iPhone App

Get breaking news, weather, sports & video directly on your iPhone.

Politics

Breaking political news & the latest headlines from the state capitol & D.C.

Radars

See where weather is happening using our live interactive radars.

Technology

Spend your money wisely with reviews of new tech gadgets & the latest news in technology.

TV Schedule

Need to know what's on TV? Check out our television schedule.

Live Radar

WARN Interactive
Powered by Frankly
News 9
7401 N. Kelley Ave.
Oklahoma City, OK 73111
News9.com is proud to provide Oklahomans with timely and relevant news and information, sharing the stories, pictures and loves of Oklahomans across our great state.
All content © Copyright 2000 - 2017 KWTV. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.